An interventional study of Daily avocado in Gut Microbiome, Neurocognitive Correlates of Eating Habits and Infant Growth, sponsored by Arizona State University. Recruiting at 1 site in United States. Open to participants aged 3 Months to 6 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by Arizona State University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 333 studies in Feeding Behavior with a site in United States — 46 open to participants now, 66 under way, 1 of them phase 3. Feeding Behavior · United States.
Among the 333 studies in Feeding Behavior with a site in United States, this one is the 70th largest by planned enrollment of the 271 interventional ones that give a count, is one of 16 that started in 2025, is one of 260 with no phase, reaches primary completion later than 56 of the 65 other live ones, and was the 309th registered.
988 studies on the registry are indexed under Feeding Behavior; 177 are open to participants now.
Browse Feeding Behavior studies →46 of the 333 studies in Feeding Behavior with a site in United States are open now. Recruiting first, the newest first:
Cornell University · Sites in United States
Ages 20–60
Arizona State University · Sites in United States
Ages 6 mo–12 mo · Healthy volunteers
Pennington Biomedical Research Center · Sites in United States
Ages 8–12 · Healthy volunteers
University of Texas at Austin · Sites in United States
Ages 30–60 · Women only · Healthy volunteers
Weill Medical College of Cornell University · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 112 Feeding Behavior studies recruiting now, 35 (31%) set no upper age limit and 71 (63%) stop at 75 or younger; 41 take children under 18; 70 take healthy volunteers.
This study: 3 Months to 6 Months · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
333 studies; the count open now beside each. This study's row is marked.
First in 1984; this study’s year is marked. 16 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 150 is above the median of 79 across 700 interventional studies indexed under Feeding Behavior.
Median enrollment 61 across the 271 interventional studies, 111 across the 62 observational. Of the 250 that completed or were terminated, 58 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 333 have an industry lead sponsor. The 10 most frequent:
Arizona State University is the lead sponsor of 239 studies on the registry; 43 are open to participants now.
Arizona State University has 5 studies filed under Feeding Behavior — fewer than ten, so there is no comparison to draw.
29 of the studies in Feeding Behavior with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07290179Pennington Biomedical Research CenterEvaluating the Validity and Feasibility of a Smartwatch-based Eating Detection System to Passively and Automatically Detect Eating Events in Child-parent Dyads | 2026-11 |
| NCT05381766NYU Langone HealthBuilding Access to Food Through Systems and Solidarity | 2026-11-30 |
| NCT06864208The Miriam HospitalAddressing Weight Bias Internalization to Improve Adolescent Weight Management Outcomes: Randomized Pilot Trial | 2026-12 |
| NCT03783507The University of Tennessee, KnoxvilleFoods Within a Meal and Food Liking Study | 2026-12 |
| NCT05943626University of UtahCircadian Intervention to Improve Cardiometabolic Health | 2026-12 |
Add all 29 to your calendar (.ics) → With an account.
Among the 333 studies in Feeding Behavior with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn if daily avocado intake can improve growth and brain and gut health in infants. The main questions it aims to answer are:
Does daily eating of avocados change which microbes live in the infant's gut? Does daily avocado intake improve infant motor skills and cognitive development?
Researchers will compare avocado intake to standard of care (no or limited avocado intake) to see if regular avocado intake from 6-12 months of life influences gut and brain health.
Participating mothers/guardians and their infants will:
Parents will provide avocado or no avocado to their infant every day for 6 months starting around 6 months of infant age.
Parents will allow study staff to visit participant homes to collect data via surveys and observations and measure infant growth.
Parents will swab soiled infant diapers for gut microbe measures. Parents will keep a diary of the infant's avocado consumption and acceptance of the food.
Parents will record their infant's dietary intake
The overarching goal of this two-arm, randomized clinical trial, is to study how early avocado exposure impacts the gut microbiome and developmental milestones in Hispanic infants. The following aims will be achieved using a randomized, parallel-arm, clinical trial.
Specific Aim 1: Evaluate how avocado consumption modulates the infant GM. Hypothesis 1: Daily avocado exposure will produce distinct structural and functional signatures within the GM compared to control.
Specific Aim 2: Investigate how avocado consumption affects emerging motor and neurocognitive skills in infants.
Hypothesis 2: Daily avocado exposure will improve development compared to the control group.
All measures will be completed at participant homes when infants are 6, 9, and 12 months of age. Infants in the intervention arm will receive a daily amount of avocado and the amount consumed will be measured. Those in the control arm will be asked to limit avocado exposure to no more than once per week.
Those in the control arm will receive the same quantity of avocados for 6 months to provide to their child once the 6-month intervention period has been completed so that control infants may also benefit from avocado consumption.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Infants in the daily avocado group will receive a daily exposure amount of avocado ranging from 1/4 (\~37.5 g or 1.25 oz) to 1/2 (\~75 g or 2.5 oz) of a medium-sized avocado.
Other: Daily avocado
Infants in the control group will be asked to limit avocado exposure to no more than 1/8 of a medium-sized avocado (\~19 g, 2 Tbs) once per week.
Infants in the daily avocado group will receive a daily exposure amount of avocado ranging from 1/4 (\~37.5 g or 1.25 oz) to 1/2 (\~75 g or 2.5 oz) of a medium-sized avocado. At 6-8 months, infants will be provided 1/4 (\~37.5 g or 1.25 oz) of a medium-sized avocado for daily consumption. Then from 9-12 months, they will begin receiving 1/2 (\~75 g or 2.5 oz) of a medium-sized avocado for daily consumption.
Gut microbiome
Parents will collect stool samples from infant diapers using sterile swabs (parent will swab a soiled diaper) and backup soiled diapers.
Time frame: At enrollment to the end of treatment at 6 months
Vineland Adaptive Behavior Scale (Vinland-3)
A questionnaire completed by the parent/caregiver that is normed for ages from birth through 90 years. The tool assesses adaptive behaviors (things people do to function in everyday life) in three domains: communication, daily living skills, and socialization.
Time frame: From enrollment to the end of treatment at 6 months
McArthur Bates Communicative Development Inventories III (MBCDI-III)
A widely used checklist completed by parents to assess children's early communication skills such as comprehension and use of gestures and words.
Time frame: From enrollment to the end of treatment at 6 months
HOME Assessment
Research personnel will objectively evaluate the caring environment in which a child is raised and parent-child interaction using this validated assessment.
Time frame: From enrollment to the end of treatment at 6 months
Mullen Scales of Early Learning
Study staff will administer a structured 15-minute play session with the infant to objectively assess motor, visual, and early language skills.
Time frame: From enrollment to the end of treatment at 6 months
Infant length
Infant length will be assessed with a pediatric length board and reported in centimeters.
Time frame: From enrollment to the end of treatment at 6 months
Infant weight
Infant weight will be assessed with a calibrated scale and reported in grams.
Time frame: From enrollment to the end of treatment at 6 months
Skin Carotenoid Concentration
The Veggie-Meter, a non-invasive measurement device, will be used to assess the carotenoid content on the index finger of the infant's right hand using reflection spectroscopy via a 2 mm wide white LED light (similar to pulse oximeter measures on the index finger).
Time frame: From enrollment to the end of treatment at 6 months
Infant 24-hour Diet Records
Habitual intake will be assessed via the Automated Self-Administered 24-hr recall software (ASA24) on 2 weekdays and one weekend day developed by the National Cancer Institute.
Time frame: From enrollment to the end of treatment at 6 months
Food intake photos
Pre-post meal photos of the infant and their food will be provided by the parents. These images will be used to help corroborate dietary intake and behavior data.
Time frame: From enrollment to the end of treatment at 6 months
Centers for Disease Control Infant Feeding Practices Study II Questionnaire
This questionnaire asks about breastfeeding, formula feeding, complementary feeding, introduction to solid foods, food allergies, and participation in the Special Supplemental Nutrition Assistance Program for Women, Infant, and Children.
Time frame: From enrollment to the end of treatment at 6 months
Food Security Screener
The USDA 6-Item Food Security Screener will be used to assess household food insecurity.
Time frame: From enrollment to the end of treatment at 6 months
Stool Consistency
Parents will be asked to classify the stool consistency using the picture-based Brussels Infant and Toddler Stool Scale (BITSS), developed specifically for non-toilet-trained children.
Time frame: From enrollment to the end of treatment at 6 months
Plan to share: Yes — To comply with the rigor and reproducibility goals of the scientific community, we will make data available when required for publication in peer-reviewed scholarly journals. Any data shared for publication will be shared in repositories such as those managed by the U.S. government (e.g. dbGAP for microbiome sequence files and associated phenotype metadata) or Arizona State University. Data will be shared with the sponsor and made available for secondary data analyses upon reasonable investigator request. Further study protocols will be made available upon request to the PI and analytical code and statistical analyses will be shared through GitHub.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: IPD and supporting information will be available no earlier than the time of first publication.
Access criteria: IPD will be accessible to investigators interested in engaging in secondary data analysis or recreating analyses done by the study team as educational exercises.
No publications or documents are linked to this record.
Started Aug 2025 (actual). Primary completion is estimated for Oct 2028, 38 months after the start.
Of 503 non-industry interventional studies with no phase under Feeding Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 38 months is above that.
Counting every sponsor, half of 515 studies reached it within 14 months; a quarter within 5 and three quarters within 31.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 29, 2026: primary completion Oct 2027 → Oct 2028 and completion Dec 2027 → Dec 2028.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.